Among nitrogen‐containing organic compounds, imidazo[1,2‐a]pyridines, and especially C3‐functionalized imidazo[1,2‐a]pyridines, have a wide range of industrial applications in the fields of optics, material science, and organometallics. This scaffolds also have various medicinal uses due to their antiviral, cytotoxic, antibacterial, fungicidal, and antiinflammatory activities as they are found in many commercially available drugs such as Alpidem, Miroprofen, and Zolimidine. In this review, we summarized and classified the latest synthetic methods for the preparation of C3‐functionalized imidazo[1,2‐a]pyridines based on the type of the substituents on the 3‐position of imidazo[1,2‐a]pyridine including C3‐alkylation, C3‐arylation, C3‐carbonylation, C3‐sulfenylation, C3‐selenation, C3‐N‐Substitution, C3‐phosphonation, and C3‐halogenation.

No abstract

No abstract

No abstract

No abstract

No abstract

This dataset deals with the modification of granular activated carbon (GAC) with FeCl3 under basic conditions (pH ≈ 12) for removal of aluminium (Al) from aqueous solution. The structural properties and operational parameters including Al ion concentration (2.15 and 10.3 mg/L), pH solution (2–10), adsorbent dosage (0.1–5 g/L), and contact time (0–10 h) was investigated for raw and modified GAC. This dataset provides information about Al removal by GAC and modified GAC at conditions including: pH = 8, contact time = 6 h, initial Al concentration = 2.15 mg/L. The characterization data of the adsorbents was analysed by Fourier transform infrared (FTIR) spectroscopy, scanning electron microscopy (SEM) and Brunauer, Emmett and Teller (BET) test. The data showed that Freundlich isotherm with and Pseudo second order kinetic model were the best models for describing the Al adsorption reactions. The acquired data indicated that the maximum adsorption capacity of GAC and modified GAC to uptake Al (C0 = 10.3 mg/L) was 3 and 4.37 mg/g respectively.

Control of brucellosis as a worldwide zoonotic disease is based on vaccination of animals and diagnosis of infected cases to be eradicated. Accurate and rapid detection of infected animals is of critical importance for preventing the spread of disease. Current detection of brucellosis is based on whole-cell antigens and investigating serum antibodies against Brucella lipopolysaccharide (LPS). The critical disadvantage is misdiagnosis of vaccinated animals as infected ones and also cross-reactions with other Gramnegative bacteria. Recombinant outer membrane protein 2b (Omp2b) of Brucella abortus was evaluated as a novel serodiagnostic target in comparison to conventional tests which are based on LPS. Recombinant Omp2b (rOmp2b) was expressed in Escherichia coli BL21 and purified by Ni 2+-based chromatography. rOmp2b was evaluated in an indirect enzyme-linked immunosorbent assay (ELISA) system for diagnosis of brucellosis, with sera from Brucella-infected mice along with negative sera and sera from mice which were inoculated with other Gram-negative species for assurance of specificity. Thereafter, cattle sera collected from different regions were assessed along with known negative and known positive serum samples. We found that Omp2b can discriminate between Brucella-infected animals and non-infected ones. Results for assessment of two hundred and fifty cattle sera by Omp2b-based indirect ELISA which were compared to Rose Bengal plate agglutination test (RBPT) and serum tube agglutination test (SAT) showed that our proposed procedure has the sensitivity of 88.5%, specificity of 100%, and accuracy of 90.8%. We suggest that recombinant Omp2b could be used as a protein antigen for diagnosis of brucellosis in domestic animals and can be evaluated for detection of human brucellosis.